HLA-B27 polymorphism at position 116 critically influences the association with TAP/tapasin, intracellular trafficking and conformational homodimers formation

Molecular Immunology

Volumn 46, Issue 7, 2009, Pages 1304-1311

  Blanco Gelaz, M A ^a   Suarez Alvarez B ^a   Diaz Pena R ^a   Lopez Larrea C ^a,b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Section of Nephrology   (Spain)

Author keywords

Antigen processing; Homodimer; Immunopathogenesis; Spondyloarthropathies

Indexed keywords

HISTIDINE; HLA B27 ANTIGEN; HOMODIMER; TAPASIN;

ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; CELL SURFACE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; ENDOPLASMIC RETICULUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELLS, CULTURED; DIMERIZATION; HLA-B27 ANTIGEN; HUMANS; MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; SPONDYLARTHROPATHIES;

EID: 62549135300     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.11.023     Document Type: Article

References (35)

1. Allen R.L., O'Callaghan C.A., McMichael A.J., and Bowness P. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J. Immunol. 62 May (9) (1999) 5045-5048
2. Antoniou A.N., Ford S., Taurog J.D., Butcher G.W., and Powis S.J. Formation of HLA-B27 homodimers and their relationship to assembly kinetics. J. Biol. Chem. 279 March (10) (2003) 8895-8902
3. Armas J.B., Gonzalez S., Martinez Borra J., Laranjeira F., Ribeiro E., Correia J., Ferreira M.L., Toste M., Lopez-Vazquez A., and Lopez-Larrea C. Susceptibility to ankylosing spondylitis is independent of the Bw4 and Bw6 epitopes of HLA-B27 alleles. Tissue Antigens 53 March (3) (1999) 237-243
4. Bird L., Peh C.A., Kollnberger S., Elliott T., McMichael A., and Bowness P. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur. J. Immunol. 33 March (3) (2003) 748-759
5. Blanco-Gelaz M.A., Suarez-Alvarez B., Gonzalez S., Lopez-Vazquez A., Martinez-Borra J., and Lópe-Larrea C. The amino acid at position 97 is involved in folding and surface expression of HLA-B27. Int. Immunol. 18 1 (2006) 211-220
6. Brewerton D.A., Hart F.D., Nicholls A., Caffrey M., James D.C., and Sturrock R.D. Ankylosing spondylitis and HL-A 27. Lancet 1 (1973) 904-907
7. Colbert R.A. HLA-B27 misfolding: a solution to the spondyloarthropathy conundrum?. Mol. Med. Today 6 June (6) (2000) 224-230
8. D'Amato M., Fiorillo M.T., Carcassi C., Mathieu A., Zucarrelli A., Bitti P.P., Tosi R., and Sorrentino R. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur. J. Immunol. 25 (1995) 3199-3201
9. Dangoria N.S., DeLay M.L., Kingsbury D.J., Mear J.P., Uchanska-Ziegler B., Ziegler A., and Colbert R.A. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J. Biol. Chem. 277 June (26) (2002) 23459-23468
10. Domena J.T., Little A.M., Madrigal A.J., Hildebrand W.H., Johnston-Dow L., du Toit E., Bias W.B., and Parham P. Structural heterogeneity in HLA-B70, a high-frequency antigen of black population. Tissue Antigens 42 (1993) 509-517
11. Ellis S.A., Taylor C., and McMichael A.J. Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum. Immunol. 5 (1982) 49-59
12. Galocha B., and Lopez de Castro J.A. Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to Ankylosing Spondylitis. Arthritis Rheum. 58 February (2) (2008) 401-412
13. Gaston H. Mechanisms of disease: the immunopathogenesis of spondyloarthropathies. Nat. Clin. Pract. Rheumatol. 2 July (7) (2006) 383-392
14. Goodall J.C., Ellis L., and Gaston J.S. Spondyloarthritis-associated and non-spondyloarthritis associated B27 subtypes differ en their dependence upon tapasin for surface expression and their incorporation into de peptide loading complex. Arthritis Rheum. 54 January (1) (2006) 138-147
15. Greenwood R., Shimizu Y., Sekhon G.S., and DeMars R. Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line. J. Immunol. 153 December (12) (1994) 5525-5536
16. Kollnberger S., Bird L., Sun M.Y., Retiere C., Braud V.M., McMichael A., and Bowness P. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum. 46 November (11) (2002) 2972-2982
17. López de Castro J.A., Álvarez I., Marcilla M., Paradela A., Ramos M., Sesma L., and Vázquez M. HLA-B27: a registry of constitutive peptide ligands. Tissue Antigens 63 May (5) (2004) 424-445
18. Lopez-Larrea C., Sujirachato K., Mehra N.K., Chiewsilp P., Isarangkura D., Kanga U., Domínguez O., Coto E., Peña M., Setién F., and González-Roces S. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 45 (1995) 169-176
19. Mear J.P., Schreiber K.L., Münz C., Zhu X., Stevanovic S., Rammense H.G., Rowland-Jones S.L., and Colbert R.A. Misfolding of HLA-B27 as a result of its B pocket suggest a novel mechanism for its role in susceptibility to spondyloarthropathies. J. Immunol. 163 (1999) 6665-6670
20. Montserrat V., Galocha B., Marcilla M., Vazquez M., and López de Castro J.A. HLA-B*2704, an allotype associated with ankylosing spondylitis, is critically dependent on transporter associated with antigen processing and relatively independent of tapasin and immunoproteasome for maturation, surface expression and T cell recognition: relationship to B*2705 and B*2706. J. Immunol. 177 (2006) 7015-7023
21. Olivieri I., D'Angelo S., Scarano E., Santospirito V., and Padula A. The HLA-B*2709 subtype in a woman with early ankylosing spondylitis. Arthritis Rheum. 56 8 (2007) 2805-2807
22. Park B., Lee S., Kim E., and Ahn K. A single polymorphic residue within the peptide-binding cleft of MHC class I molecules determines spectrum of tapasin dependence. J. Immunol. 170 January (2) (2003) 961-968
23. Peh C.A., Burrows S.R., Barnden M., Khanna R., Cresswell P., Moss D.J., and McClaskey J. HLA-B27 restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 8 May (5) (1998) 531-542
24. Perosa F., Luccarelli G., Prete M., Faviono E., Ferrones S., and Dammanco F. β2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC10-specific peptide. J. Immunol. 171 (2003) 1918-1926
25. Purcell A.W., Gorman J.J., Garcia-Peydró M., Paradela A., Burrows S.R., Talbo G.H., Laham N., Peh C.A., Reynolds E.C., López De Castro J.A., and McCluskey J. Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J. Immunol. 166 January (2) (2001) 1016-1027
26. Purcell A.W., Kelly A.J., Peh C.A., Dudek N.L., and McCluskey J. Endogenous and exogenous factors contributing to the surface expression of HLA B27 on mutant APC. Hum. Immunol. 61 February (2) (2000) 120-130
27. Schimd I., Krall W.J., Uittenbogaart C.H., Braun J., and Giorgi J.V. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 13 (1992) 204-208
28. Schlosstein L., Terasaki T.I., Bluestone R., and Pearson C.M. High association of an HLA antigen, W27, with ankylosing spondylitis. New Engl. J. Med. 288 (1973) 704-706
29. Shimizu Y., and DeMars R. Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line. J. Immunol. 142 (1989) 3320-3328
30. Stam N.J., Spits H., and Ploegh H.L. Monoclonal antibodies raised against denatured HLA-B locus heavy chain permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137 (1986) 2299-2306
31. Taurug J.D. The mystery of HLA-B27: if it isn't one thing, it's another. Arthritis Rheum. 56 8 (2007) 2478-2481
32. Thammavongsa V., Raughuraman G., Filzen T.M., Collins K.L., and Raghavan M. HLA-B44 polymorphism at position 116 of the heavy chain influence TAP complex binding via an effect on peptide occupancy. J. Immunol. 177 September (5) (2006) 3150-3161
33. Tran T.M., Satuntira N., Dorris M.L., May E., Wang A., Furuta E., and Taurog J.D. HLA-B27 in transgenic rats forms disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BIP. J. Immunol. 172 (2004) 5110-5119
34. Turnquist H.R., Thomas H.J., Prilliman K.R., Lutz C.T., Hildebrand W.H., and Solheim J. HLA-B polymorphism affects interactions with multiple endoplasmic reticulum proteins. Eur. J. Immunol. 30 October (10) (2000) 3021-3028
35. Zemmour J., Little A.M., Schendel D.J., and Parham P. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148 March (6) (1992) 1941-1948